Graph receives the Deep Tech Life Science Seed Financing grant from the Austria Wirthschafts Service (AWS) worth EUR 1.1M! This accelerates our AI-driven platform technology and lab-in-the-loop approach to discover better data, targets, validation & biomarkers for immune & inflammatory diseases. 🎯🧬

Anyone around Milan 🇮🇹 from 17 - 19 March? We’ll be there! Come and say Ciao! to our CEO & cofounder @gregvladimer.bsky.social and connect with us at BIO-Europe Spring!

🔬🧬 AI x bio arrives in Paris! Come say Salut! to Graph's @kdris.bsky.social & the techbio community for the @techbio.bsky.social x @bitsinbio.bsky.social meetup, co-hosted with ORAKL Oncology, Speedinvest, & BioLabs. 25 Feb @ 18:30. Join the waitlist: lu.ma/3vavwseg

Graph Therapeutics announces the closing of a $3.1M pre-seed round aimed at bringing the precision medicine paradigm to inflammation and immunology (I&I). 🚀🔬🧬 Looking forward to great things to come! Read more ➡️ graphtx.com/news#graph-p...